La terapia de infusión casera de OptiMed mantiene a los pacientes en el camino de su cuidado mientras reduce el riesgo de COVID-19

La Asociación Nacional de Infusiones Domésticas emite recomendaciones para promover la seguridad del paciente y contener los costos

KALAMAZOO, Mich., April 6, 2020 (Newswire.com) - As COVID-19 cases spread rapidly across the U.S., there is a new call by the National Home Infusion Association (NHIA) to treat patients needing specialty infusions in their homes offered by OptiMed, a home infusion pharmacy with national capabilities.

La NHIA, que es una de las principales voces en materia de terapia de infusión en el hogar, emitió una declaración el 30 de marzo en la que alentaba a la utilización de la infusión en el hogar para ayudar a los pacientes a seguir con su terapia y reducir el riesgo de exposición a COVID-19.

"Home infusion pharmacies have safely and effectively treated patients in the home for decades," the statement reads. "While the demand for these services by commercial payers has been largely focused on the cost-effectiveness of home infusion, this site of care has the additional benefits of freeing up hospital resources to treat those most in need and limiting exposure to pathogens. This makes home infusion a powerful tool in the fight against COVID-19."

Andy Reeves, CEO of Michigan-based OptiMed, said there’s already been an increase in transitioning patients to home infusion therapy in the past two weeks because of COVID-19. He said home infusion is not only safer and more convenient but typically is less costly.

La infusión casera consiste en que una enfermera proporcione la infusión del paciente en la comodidad de su hogar. Los proveedores de terapia coordinan el cuidado del paciente a través de un equipo de profesionales altamente capacitados, incluyendo un farmacéutico de infusiones, enfermeras de infusiones, gerentes de cuidado y el proveedor que prescribe, lo que asegura que el paciente esté recibiendo un tratamiento óptimo.

“Our expertise has always been delivering patient-centered care that is safe, timely, clinically sound, and cost-effective,” said Reeves. “During COVID-19, we are committed to providing an impactful solution for patients, payers, and health systems through our ability to expeditiously transition patients on specialty infusions to receive care safely in their homes.”

About OptiMed:  OptiMed Health Partners, headquartered in Kalamazoo, Michigan, is an independently owned and operated national healthcare organization. With over 25 years of experience, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other healthcare organizations to usher in a new standard of excellence. To learn more about OptiMed’s innovative and personalized care, visit OptiMedHP.com.

If you or someone you know is receiving infused or injected therapies, please contact OptiMed at 877-232-2857 to discuss treatment options and the benefits of in-home services.